Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice-Reference-Cited by-同舟云学术

Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice

Published:2024-08-03 Issue:5 Volume:13 Page:1321-1335
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Yamout Bassem,Alroughani Raed,Inshasi Jihad,Farouk Samar,Abdulla Fatema,Al-Jarki Namareq Y.,Alasmi Abdulla,Al Fahad Sarmad,Alkhabouri Jaber,Al-Saffar Khalid,Benedetti Beatrice,Canibano Beatriz,Deleu Dirk,Hassan Ali,Sarathchandran Pournamy,Shatila Ahmed,Abouelnaga Mohammad,Thakre Mona,Szolics Miklos,Boshra Amir

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40120-024-00650-5.pdf

Reference46 articles.

1. AlSharoqi IA, Aljumah M, Bohlega S, et al. Immune reconstitution therapy or continuous immunosuppression for the management of active relapsing-remitting multiple sclerosis patients? a narrative review. Neurol Ther. 2020;9:55–66.

2. Sorensen PS, Sellebjerg F. Pulsed immune reconstitution therapy in multiple sclerosis. Ther Adv Neurol Disord. 2019;28(12):1756286419836913.

3. De Sèze J, Suchet L, Mekies C, et al. The place of immune reconstitution therapy in the management of relapsing multiple sclerosis in France: an expert consensus. Neurol Ther. 2023;12:351–69.

4. Giovannoni G, Mathews J. Cladribine tablets for relapsing-remitting multiple sclerosis: a clinician’s review. Neurol Ther. 2022;11:571–95.

5. Comi G, Cook S, Giovannoni G, et al. Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis. Mult Scler Relat Disord. 2019;29:168–74.